Philadelphia’s Office of Business Development awarded $450,000 in matching grants to 21 life sciences companies, the first ...

Local biotech entrepreneurs and investors are seeing signs that the four-year "biotech winter" is finally thawing, though ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

Anas Alteimi, Director of the Healthcare Sector at the Ministry of Investment in Saudi Arabia, discusses the Kingdom’s major ...

The discussion focuses on how KAIMRC integrates clinical research, biobanking, data infrastructure, and translational science ...

While GLP-1 (glucagon-like peptide-1) class obesity treatments like ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Carvykti sales surge, MRD FDA guidance speeds label expansion, and strong cash runway. Click for more on LEGN stock.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...